Cell Line Development Market Share, Size, and Outlook by 2031
Cell Line Development Market: Strategic Insights
Cell Line Development Market
-
CAGR (2023 - 2031)13.3% -
Market Size 2023
US$ 6.86 Billion -
Market Size 2031
US$ 18.62 Billion
Market Dynamics
GROWTH DRIVERS
- Rise in Production of Vaccine
FUTURE TRENDS
- Ongoing Advancements in Cell Line Engineering and Robust Development in Cell Line Technology
OPPORTUNITIES
- Significant Opportunities in Emerging Market
Key Players
- Thermo Fisher Scientific Inc
- Merck KGaA
- Selexis SA JSR Corporation
- BioFactura Inc
- Corning Incorporated
- Sartorius AG
- Lonza
- GENERAL ELECTRIC
- LakePharma Inc
- WuXi AppTec Group
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Type
- Primary Cell Line
- Hybridomas
- Continuous Cell Lines
- Recombinant Cell Line
Product
- Equipment
- Media
- Reagent
Application
- Drug Discovery
- Bioproduction
- Tissue Engineering